Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis.
about
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisCurrent application of proteomics in biomarker discovery for inflammatory bowel diseaseIndications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.Five-aminosalicylic Acid: an update for the reappraisal of an old drugOptimizing management of distal ulcerative colitis.5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.The risks and the benefits of mesalazine as a treatment for ulcerative colitis.Renal effects of long-term treatment with 5-aminosalicylic acidRenal manifestations and complications of inflammatory bowel disease.Are there any differences in the efficacy and safety of different formulations of Oral 5-ASA used for induction and maintenance of remission in ulcerative colitis? evidence from cochrane reviews.Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis.A new oral delivery system for 5-ASA: preliminary clinical findings for MMx.5-Aminosalicylates and effects on renal function in patients with Crohn's disease.
P2860
Q24185774-59D8A8DB-1CC4-4527-AB84-1A35C55B3804Q24198786-7C60B228-4032-4BC5-A913-9D39F8194755Q24246085-5877FBE5-96E0-45BD-B466-C33B748562A6Q28078755-2454223D-E83F-4139-8644-5AA520FC771CQ33868970-96AE608D-2831-4A4B-A3FA-BF0AC86FC8A4Q34529943-6159BF5F-44DB-4DF4-92BC-DCA6DE2779D8Q35061210-8D51E7FC-1114-467F-9F09-3499696527BBQ36459902-8BC6DB0A-CC3F-442E-AC93-530681E6158BQ36715466-3D62EC65-65A5-4F34-BC6D-FE1F19540066Q36762423-025712BD-E369-4CD0-9A20-DBE324E4CB14Q37223156-3C272B00-4A54-4130-BE63-787171D9991AQ37789000-70706CE7-0B7D-4B4D-B6BB-C8A8FE34C931Q38118053-B5D0547A-C1B4-4E42-862C-08D84C982646Q44255869-F415697D-0550-42CE-8FF2-386F2547EABDQ46469247-B14E4C0A-010A-4BD1-A9FB-A67A273E2020Q46766282-EE2936E6-D5B2-4D09-BC86-A580032875F0
P2860
Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Evaluation of renal function f ...... ients with ulcerative colitis.
@en
Evaluation of renal function f ...... ients with ulcerative colitis.
@nl
type
label
Evaluation of renal function f ...... ients with ulcerative colitis.
@en
Evaluation of renal function f ...... ients with ulcerative colitis.
@nl
prefLabel
Evaluation of renal function f ...... ients with ulcerative colitis.
@en
Evaluation of renal function f ...... ients with ulcerative colitis.
@nl
P2093
P2860
P1476
Evaluation of renal function f ...... ients with ulcerative colitis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2002.01155.X
P407
P577
2002-02-01T00:00:00Z